$232+ Million GAS Pharyngitis Diagnostics Industry Assessment 2019-2027 - Includes Profiles of Abbott Labs, BD, Beckman Coulter, bioMerieux, DiaSorin, and More - ResearchAndMarkets.com

The "GAS Pharyngitis Diagnostics - Global Market Outlook (2019-2027)" report has been added to ResearchAndMarkets.com's offering.

The Global GAS Pharyngitis Diagnostics market accounted for $169.88 million in 2019 and is expected to reach $232.5 million by 2027, growing at a CAGR of 4% during the forecast period.

Incidence and prevalence of gas pharyngitis infections are gradually growing across the globe and thereby driving the growth of the market. However, issues in providing accurate, efficient, and accessible diagnostics are restraining the growth of the market.

Based on the product, the rapid test kit segment is likely to have a huge demand due to the development for rapid point-of-care diagnosis mainly to be used in physician clinics and hospitals. Furthermore, ease of use and low cost per test are major factors expected to drive the segment.

By geography, North America is estimated to have a lucrative growth due to the favourable reimbursement facilities, high alertness among patients for GAS infection, rapid adoption of advanced tests, and presence of major players who constantly promote their brands through wide distribution channels are key factors pouring the market in the region.

Some of the key players profiled in the GAS Pharyngitis Diagnostics Market include Abbott Laboratories, BD, Beckman Coulter, Inc. (Danaher), bioMerieux SA, DiaSorin S.p.A., F. Hoffmann-La Roche Ltd, Meridian Bioscience, Inc., Quidel Corporation and Sekisui Diagnostics.

What the report offers:

• Market share assessments for the regional and country-level segments
• Strategic recommendations for the new entrants
• Covers Market data for the years 2018, 2019, 2020, 2024 and 2027
• Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
• Strategic recommendations in key business segments based on the market estimations
• Competitive landscaping mapping the key common trends
• Company Profiling with detailed strategies, financials, and recent developments
• Supply chain trends mapping the latest technological advancements

Key Topics Covered

1 Executive Summary

2 Preface

3 Market Trend Analysis

3.1 Introduction

3.2 Drivers

3.3 Restraints

3.4 Opportunities

3.5 Threats

3.6 Product Analysis

3.7 End-user Analysis

3.8 Emerging Markets

3.9 Impact of COVID-19

4 Porters Five Force Analysis

5 Global GAS Pharyngitis Diagnostics Market, By Product

5.1 Introduction

5.2 PCR-based Test

5.3 Rapid Test Kit

5.4 Culture Test

6 Global GAS Pharyngitis Diagnostics Market, By End User

6.1 Introduction

6.2 Diagnostics Laboratories

6.3 Hospitals

6.4 Physician Clinics

7 Global GAS Pharyngitis Diagnostics Market, By Geography

7.1 Introduction

7.2 North America

7.2.1 US

7.2.2 Canada

7.2.3 Mexico

7.3 Europe

7.3.1 Germany

7.3.2 UK

7.3.3 Italy

7.3.4 France

7.3.5 Spain

7.3.6 Rest of Europe

7.4 Asia-Pacific

7.4.1 Japan

7.4.2 China

7.4.3 India

7.4.4 Australia

7.4.5 New Zealand

7.4.6 South Korea

7.4.7 Rest of Asia-Pacific

7.5 South America

7.5.1 Argentina

7.5.2 Brazil

7.5.3 Chile

7.5.4 Rest of South America

7.6 Middle East & Africa

7.6.1 Saudi Arabia

7.6.2 UAE

7.6.3 Qatar

7.6.4 South Africa

7.6.5 Rest of Middle East & Africa

8 Key Developments

8.1 Agreements, Partnerships, Collaborations and Joint Ventures

8.2 Acquisitions & Mergers

8.3 New Product Launch

8.4 Expansions

8.5 Other Key Strategies

9 Company Profiling

9.1 Abbott Laboratories

9.2 BD

9.3 Beckman Coulter, Inc. (Danaher)

9.4 bioMerieux S.A.

9.5 DiaSorin S.p.A.

9.6 F. Hoffmann-La Roche Ltd.

9.7 Meridian Bioscience, Inc.

9.8 Quidel Corporation

9.9 Sekisui Diagnostics

For more information about this report visit https://www.researchandmarkets.com/r/yqymts

View source version on businesswire.com: https://www.businesswire.com/news/home/20200623005520/en/